STOCK ALARM
SA
Menu
Demo
Log In
Atlas
News
Feed
Alerts
Portfolio
Screener
Picks
Charts
Movers
Earnings
Updates
IMPL
(IMPL)
IMPL
Overview
Notebook
Intelligence
Chart
History
Fundmntls
TTM
Earnings
Analysts
News
Financials
Segments
Insiders
Institl.
DCF
Peers
Trailing Twelve Months (TTM) Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Home
Screener
Alerts
Search
More
Per Share (TTM)
Revenue/Share
$0.54
Net Income/Share
$-5.52
Operating CF/Share
$-3.99
Free CF/Share
$-4.05
Cash/Share
$2.59
Book Value/Share
$-1.88
Tangible Book/Share
$-1.88
Equity/Share
$-1.88
Interest Debt/Share
$2.77
CapEx/Share
$0.06
Dividend/Share
$0.00
Valuation
Market Cap
$956.00K
Enterprise Value
-$8.51M
P/E Ratio
-0.01
P/S Ratio
0.08
P/OCF Ratio
-0.01
P/FCF Ratio
-0.01
P/B Ratio
-0.02
P/TB Ratio
-0.02
EV/Sales
-0.67
EV/EBITDA
0.09
Graham Valuation
Graham Number
--
Graham Net-Net
$-2.66
Profitability
Earnings Yield
-13802.46%
FCF Yield
-9939.23%
ROE
-3099.99%
ROIC
-122.46%
Return on Tangible Assets
-146.18%
Dividend
Dividend Yield
0.00%
Payout Ratio
0.00%
Capital Allocation
CapEx/OCF
-1.47%
CapEx/Revenue
10.88%
CapEx/Depreciation
1.15
SBC/Revenue
41.03%
SG&A/Revenue
615.59%
R&D/Revenue
90.55%
Liquidity & Solvency
Debt/Equity
-1.16
Debt/Assets
0.58
Debt/Market Cap
53.54
Net Debt/EBITDA
0.10
Current Ratio
3.60
Interest Coverage
-6.01x
Income Quality
0.88
Efficiency
Days Sales Outstanding
215 days
Days Payables Outstanding
342 days
Days Inventory
474 days
Receivables Turnover
1.70x
Payables Turnover
1.07x
Inventory Turnover
0.77x
Capital Structure
Tangible Assets
-$44.16M
Working Capital
$57.65M
Invested Capital
$64.64M
Intangibles/Assets
0.00%
Impel Pharmaceuticals Inc.
(IMPL)
$0.04
—
Chart
Share
Post on X
IMPL
Impel Pharmaceuticals Inc.
(IMPL)
NASDAQ
$0.04
—
Chart Studio
Share
IMPL